HDAC Inhibitors Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global HDAC (histone deacetylase) inhibitors market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global HDAC (histone deacetylase) inhibitors market 2017 - 2021 ($ million)
4.2 Route of administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral HDAC inhibitors - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
6.4 Parenteral HDAC inhibitors - Market size and forecast 2022-2027
Exhibit 38: Chart on Parenteral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Parenteral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Parenteral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Parenteral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Route of Administration
Exhibit 42: Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 43: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 44: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 45: Chart on Comparison by Distribution Channel
Exhibit 46: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 47: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 51: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Distribution Channel
Exhibit 63: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 65: Chart on Market share by geography 2022-2027 (%)
Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 105: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 108: Overview on factors of disruption
11.4 Industry risks
Exhibit 109: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 110: Vendors covered
12.2 Market positioning of vendors
Exhibit 111: Matrix on vendor position and classification
12.3 Acrotech Biopharma Inc.
Exhibit 112: Acrotech Biopharma Inc. - Overview
Exhibit 113: Acrotech Biopharma Inc. - Product / Service
Exhibit 114: Acrotech Biopharma Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 115: AstraZeneca Plc - Overview
Exhibit 116: AstraZeneca Plc - Product / Service
Exhibit 117: AstraZeneca Plc - Key news
Exhibit 118: AstraZeneca Plc - Key offerings
12.5 Bristol Myers Squibb Co.
Exhibit 119: Bristol Myers Squibb Co. - Overview
Exhibit 120: Bristol Myers Squibb Co. - Product / Service
Exhibit 121: Bristol Myers Squibb Co. - Key news
Exhibit 122: Bristol Myers Squibb Co. - Key offerings
12.6 Celleron Therapeutics Ltd.
Exhibit 123: Celleron Therapeutics Ltd. - Overview
Exhibit 124: Celleron Therapeutics Ltd. - Key offerings
12.7 Curis Inc.
Exhibit 125: Curis Inc. - Overview
Exhibit 126: Curis Inc. - Product / Service
Exhibit 127: Curis Inc. - Key offerings
12.8 Huya Bioscience International LLC
Exhibit 128: Huya Bioscience International LLC - Overview
Exhibit 129: Huya Bioscience International LLC - Product / Service
Exhibit 130: Huya Bioscience International LLC - Key offerings
12.9 Italfarmaco Spa
Exhibit 131: Italfarmaco Spa - Overview
Exhibit 132: Italfarmaco Spa - Product / Service
Exhibit 133: Italfarmaco Spa - Key offerings
12.10 Medivir AB
Exhibit 134: Medivir AB - Overview
Exhibit 135: Medivir AB - Product / Service
Exhibit 136: Medivir AB - Key offerings
12.11 Merck and Co. Inc.
Exhibit 137: Merck and Co. Inc. - Overview
Exhibit 138: Merck and Co. Inc. - Business segments
Exhibit 139: Merck and Co. Inc. - Key news
Exhibit 140: Merck and Co. Inc. - Key offerings
Exhibit 141: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 142: Novartis AG - Overview
Exhibit 143: Novartis AG - Business segments
Exhibit 144: Novartis AG - Key offerings
Exhibit 145: Novartis AG - Segment focus
12.13 Onxeo SA
Exhibit 146: Onxeo SA - Overview
Exhibit 147: Onxeo SA - Product / Service
Exhibit 148: Onxeo SA - Key offerings
12.14 Shenzhen Chipscreen Biotechnology Co. Ltd.
Exhibit 149: Shenzhen Chipscreen Biotechnology Co. Ltd. - Overview
Exhibit 150: Shenzhen Chipscreen Biotechnology Co. Ltd. - Product / Service
Exhibit 151: Shenzhen Chipscreen Biotechnology Co. Ltd. - Key offerings
12.15 Syndax Pharmaceuticals Inc.
Exhibit 152: Syndax Pharmaceuticals Inc. - Overview
Exhibit 153: Syndax Pharmaceuticals Inc. - Key offerings
12.16 Viracta Therapeutics Inc.
Exhibit 154: Viracta Therapeutics Inc. - Overview
Exhibit 155: Viracta Therapeutics Inc. - Product / Service
Exhibit 156: Viracta Therapeutics Inc. - Key offerings
12.17 Xynomic Pharmaceuticals (Nanjing) Co. Ltd.
Exhibit 157: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Overview
Exhibit 158: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Product / Service
Exhibit 159: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 160: Inclusions checklist
Exhibit 161: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 162: Currency conversion rates for US$
13.4 Research methodology
Exhibit 163: Research methodology
Exhibit 164: Validation techniques employed for market sizing
Exhibit 165: Information sources
13.5 List of abbreviations
Exhibit 166: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global HDAC (histone deacetylase) inhibitors market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits 31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Route of Administration
Exhibits 33: Data Table on Comparison by Route of Administration
Exhibits 34: Chart on Oral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Oral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Oral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Oral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Parenteral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Parenteral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Parenteral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Parenteral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Route of Administration ($ million)
Exhibits 43: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 44: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Distribution Channel
Exhibits 46: Data Table on Comparison by Distribution Channel
Exhibits 47: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 63: Market opportunity by Distribution Channel ($ million)
Exhibits 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 65: Chart on Market share by geography 2022-2027 (%)
Exhibits 66: Data Table on Market share by geography 2022-2027 (%)
Exhibits 67: Chart on Geographic comparison
Exhibits 68: Data Table on Geographic comparison
Exhibits 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 105: Market opportunity by geography ($ million)
Exhibits 106: Impact of drivers and challenges in 2022 and 2027
Exhibits 107: Overview on Criticality of inputs and Factors of differentiation
Exhibits 108: Overview on factors of disruption
Exhibits 109: Impact of key risks on business
Exhibits 110: Vendors covered
Exhibits 111: Matrix on vendor position and classification
Exhibits 112: Acrotech Biopharma Inc. - Overview
Exhibits 113: Acrotech Biopharma Inc. - Product / Service
Exhibits 114: Acrotech Biopharma Inc. - Key offerings
Exhibits 115: AstraZeneca Plc - Overview
Exhibits 116: AstraZeneca Plc - Product / Service
Exhibits 117: AstraZeneca Plc - Key news
Exhibits 118: AstraZeneca Plc - Key offerings
Exhibits 119: Bristol Myers Squibb Co. - Overview
Exhibits 120: Bristol Myers Squibb Co. - Product / Service
Exhibits 121: Bristol Myers Squibb Co. - Key news
Exhibits 122: Bristol Myers Squibb Co. - Key offerings
Exhibits 123: Celleron Therapeutics Ltd. - Overview
Exhibits 124: Celleron Therapeutics Ltd. - Key offerings
Exhibits 125: Curis Inc. - Overview
Exhibits 126: Curis Inc. - Product / Service
Exhibits 127: Curis Inc. - Key offerings
Exhibits 128: Huya Bioscience International LLC - Overview
Exhibits 129: Huya Bioscience International LLC - Product / Service
Exhibits 130: Huya Bioscience International LLC - Key offerings
Exhibits 131: Italfarmaco Spa - Overview
Exhibits 132: Italfarmaco Spa - Product / Service
Exhibits 133: Italfarmaco Spa - Key offerings
Exhibits 134: Medivir AB - Overview
Exhibits 135: Medivir AB - Product / Service
Exhibits 136: Medivir AB - Key offerings
Exhibits 137: Merck and Co. Inc. - Overview
Exhibits 138: Merck and Co. Inc. - Business segments
Exhibits 139: Merck and Co. Inc. - Key news
Exhibits 140: Merck and Co. Inc. - Key offerings
Exhibits 141: Merck and Co. Inc. - Segment focus
Exhibits 142: Novartis AG - Overview
Exhibits 143: Novartis AG - Business segments
Exhibits 144: Novartis AG - Key offerings
Exhibits 145: Novartis AG - Segment focus
Exhibits 146: Onxeo SA - Overview
Exhibits 147: Onxeo SA - Product / Service
Exhibits 148: Onxeo SA - Key offerings
Exhibits 149: Shenzhen Chipscreen Biotechnology Co. Ltd. - Overview
Exhibits 150: Shenzhen Chipscreen Biotechnology Co. Ltd. - Product / Service
Exhibits 151: Shenzhen Chipscreen Biotechnology Co. Ltd. - Key offerings
Exhibits 152: Syndax Pharmaceuticals Inc. - Overview
Exhibits 153: Syndax Pharmaceuticals Inc. - Key offerings
Exhibits 154: Viracta Therapeutics Inc. - Overview
Exhibits 155: Viracta Therapeutics Inc. - Product / Service
Exhibits 156: Viracta Therapeutics Inc. - Key offerings
Exhibits 157: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Overview
Exhibits 158: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Product / Service
Exhibits 159: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Key offerings
Exhibits 160: Inclusions checklist
Exhibits 161: Exclusions checklist
Exhibits 162: Currency conversion rates for US$
Exhibits 163: Research methodology
Exhibits 164: Validation techniques employed for market sizing
Exhibits 165: Information sources
Exhibits 166: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global HDAC (histone deacetylase) inhibitors market: Acrotech Biopharma Inc., AstraZeneca Plc, Bio Techne Corp., BioVision Inc., Bristol Myers Squibb Co., Celleron Therapeutics Ltd., Curis Inc., Huya Bioscience International LLC, InvivoGen Corp., Italfarmaco Spa, Medivir AB, Merck and Co. Inc., Novartis AG, Onxeo SA, Shenzhen Chipscreen Biotechnology Co. Ltd., Syndax Pharmaceuticals Inc., Tokyo Chemical Industry Co. Ltd., Viracta Therapeutics Inc., Xynomic Pharmaceuticals (Nanjing) Co. Ltd., and Cetya Therapeutics Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the growing geriatric population.`

According to the report, one of the major drivers for this market is the high target affinity and specificity.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• Acrotech Biopharma Inc.
• AstraZeneca Plc
• Bio Techne Corp.
• BioVision Inc.
• Bristol Myers Squibb Co.
• Celleron Therapeutics Ltd.
• Curis Inc.
• Huya Bioscience International LLC
• InvivoGen Corp.
• Italfarmaco Spa
• Medivir AB
• Merck and Co. Inc.
• Novartis AG
• Onxeo SA
• Shenzhen Chipscreen Biotechnology Co. Ltd.
• Syndax Pharmaceuticals Inc.
• Tokyo Chemical Industry Co. Ltd.
• Viracta Therapeutics Inc.
• Xynomic Pharmaceuticals (Nanjing) Co. Ltd.
• Cetya Therapeutics Inc.